Psychotic Disorders - Malaysia | Statista Market Forecast

Revenue in the Psychotic Disorders market is projected to reach US$26.77m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -0.03%, resulting in a market volume of US$26.73m by 2029.
In global comparison, most revenue will be generated United States (US$2.26bn in 2024).
In relation to total population figures, per person revenues of US$110.60 are generated in 2024.

Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies

Antipsychotic drugs: Aripiprazole (Abilify), Asenapine (Saphris), Cariprazine (Vraylar), Clozapine (Clozaril, Versacloz), lumateperone (Caplyta), Lurasidone (Latuda), Olanzapine (Zyprexa), Quetiapine (Seroquel), Risperidone (Risperdal), Risperidone (Aristada), Ziprasidone (Geodon), Brexpiprazole (Rexulti), Iloperidone (Fanapt), and Paliperidone (Invega)

Psychotherapy
Talk therapy
Herbal medicines
Digital health apps
Deep Brain Stimulation (DBS)

The Psychotic Disorders market in Malaysia is experiencing significant growth due to several factors.

Customer preferences: In Malaysia, there is a growing demand for effective treatments and therapies for psychotic disorders. Customers are increasingly seeking out innovative and evidence-based solutions to manage these conditions. They are looking for medications and therapies that can help alleviate symptoms and improve their quality of life. Additionally, customers are also interested in holistic approaches that address both the physical and mental aspects of these disorders.

Trends in the market: One of the key trends in the psychotic disorders market in Malaysia is the increasing use of technology in treatment and management. Telemedicine and digital health platforms are gaining popularity, allowing patients to access mental health services remotely. This trend is driven by the need for convenient and accessible care, especially in rural areas where access to mental health professionals may be limited. Furthermore, there is a growing interest in the use of virtual reality and other immersive technologies for therapeutic purposes, providing patients with new and engaging ways to manage their symptoms.Another trend in the market is the focus on personalized medicine. Healthcare providers are increasingly tailoring treatment plans to individual patients based on their unique genetic makeup and other factors. This approach allows for more targeted and effective treatments, improving patient outcomes. Additionally, there is a growing emphasis on early intervention and prevention strategies, as research has shown that early detection and treatment can significantly improve long-term outcomes for individuals with psychotic disorders.

Local special circumstances: Malaysia has a relatively high prevalence of psychotic disorders compared to other countries in the region. This may be attributed to various factors, including genetic predisposition, environmental factors, and cultural influences. The Malaysian government has recognized the importance of addressing mental health issues and has implemented several initiatives to improve access to mental health services. This includes the integration of mental health services into primary healthcare settings and the establishment of specialized mental health facilities.

Underlying macroeconomic factors: The growing market for psychotic disorders in Malaysia is also influenced by macroeconomic factors. The country has experienced steady economic growth in recent years, resulting in an increase in disposable income and healthcare spending. This has led to greater affordability and accessibility of mental health services and treatments. Additionally, the government's commitment to healthcare development and investment in healthcare infrastructure has further contributed to the growth of the market.In conclusion, the Psychotic Disorders market in Malaysia is growing due to customer preferences for effective treatments, the adoption of technology in mental health care, the focus on personalized medicine, the high prevalence of psychotic disorders in the country, and the underlying macroeconomic factors. With the continued focus on mental health and the implementation of innovative approaches, the market is expected to further expand in the coming years.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.